The effects of excipients on the protein stability during lyophilization as well as the storage stability of lyophilized bilirubin oxidase (BO) and b b-galactosidase (GA) formulations were studied using four polymer excipients: dextran, polyvinylalcohol (PVA), poly(acrylic acid) (PAA), and a a, , b b-poly(N-hydroxyethyl)-L-aspartamide (PHEA). Denaturation of BO and GA during lyophilization largely depended on the excipient used. Dextran appeared to cause severe damage to proteins, whereas PHEA protected proteins effectively from denaturation. Storage stability of BO and GA formulations also depended on the excipients, such that the formulations containing dextran and PAA were relatively unstable. Storage stability was improved by absorption of a small amount of water for all the formulations studied. Absorption of a larger amount of water, however, decreased the storage stability of the formulations containing PVA, PAA or PHEA. In contrast, the storage stability of formulations containing dextran did not decrease noticeably with increasing water. This may be because formulations containing dextran have a higher glass transition temperature than formulations containing PVA, PAA or PHEA when a large amount of water is absorbed.
Lyophilization is considered to be a very promising formulation for proteins susceptible to chemical and physical degradation. 1) Protein stability during lyophilization is largely affected by the excipients used in the formulations. Excipients that hydrogen bond to proteins can inhibit protein degradation during dehydration. Furthermore, excipients that produce amorphous phase having a high collapse temperature can also prevent proteins from degradation. 1) On the other hand, excipients that induce phase separation during lyophilization generally enhance protein degradation.
2) Thus, the choice of optimal excipients plays an important role in improving protein stability during lyophilization.
The choice of excipients is also important for the storage stability of lyophilized protein formulations. Excipients that have a higher glass transition temperature (T g ) in the dry state can provide lyophilized formulations of higher T g , which exhibit lower molecular mobility, and consequently tend to offer better storage stability. [3] [4] [5] Excipients that lower the T g of lyophilized formulations to a temperature close to ordinary operating temperature upon moisture absorption,on the other hand, may decrease storage stability. 6) In the present study, the effects of excipients on the protein stability during lyophilization, as well as the storage stability of lyophilized bilirubin oxidase (BO) and b-galactosidase (GA) formulations were studied using four polymer excipients: dextran, polyvinylalcohol (PVA), poly(acrylic acid) (PAA), and a,b-poly(N-hydroxyethyl)-L-aspartamide (PHEA).
Experimental
Materials GA from Aspergillus oryzae was purchased from Toyobo Co. (Osaka) and used without further purification. Bovine serum g-globulin (BGG, G5009) and bovine serum albumin (BSA, fraction V) was provided by Sigma Chemical Co., Inc. (St. Louis, MO). Lyophilized BO (Myrothecium verrucaria) powder containing 25% sucrose and 25% ammonium sulfate was kindly provided by Amano Pharmaceutical Co. (Nagoya). BO was purified by dialysis and lyophilized as described previously. 7) Dextran (D-4133, average molecular weight of 42000) was obtained from Sigma Chemical Co., Inc. PVA (average molecular weight of 31000-50000) and PAA (32366-7, average molecular weight of 2000) were purchased from Aldrich Chemical Co., Inc. (Milwaukee, WI). PAA was dissolved in water (80 mg/ml), titrated to pH 7.0 with 2.5 N NaOH solution, and lyophilized. PHEA was prepared via polysuccinimide by polycondensation of aspartic acid as reported. 8) All other chemicals were of reagent grade and purchased from Wako Pure Chemical Industries Ltd. (Osaka).
Preparation of Lyophilized BO and GA Formulations Protein (BO, GA) was dissolved in distilled water (0.8 mg/g), and mixed with an equivalent weight of aqueous solutions of polymer excipients (PVA, PHEA, dextran, PAA) (80 mg/g). The weight ratio of protein to excipient was 1 : 100. Three hundred microliters of the solution was frozen in a polypropylene sample tube (10 mm diameter) by immersion in liquid nitrogen for 10 min, and then dried in a vacuum below 5 Pa for 23.5 h in a lyophilizer (Freezevac C-1, Tozai Tsusho Co., Tokyo), as previously described.
9) The shelf temperature was between Ϫ35 and Ϫ30°C for the first 1 h, 20°C for the subsequent 19 h, and 30°C for the last 3.5 h.
Solid-State Rehydration and Storage Testing
For solid-state rehydration, lyophilized samples were stored at 15°C for 24 h in a desiccator with a saturated solution of potassium acetate (23.4% relative humidity (RH)), CaCl 2 6H 2 O (35.7%RH), K 2 CO 3 2H 2 O (43%RH), or NaBr 2H 2 O (60.2%RH). Then, water content was determined by the Karl Fisher method (684 KF Coulometer, Switzerland) ( Table 1 ). The lyophilized samples before and after solid-state rehydration were stored at 70°C for 5 h.
Determination of Enzyme Activity of Lyophilized BO and GA Formulations Enzyme activity of BO was determined as described previously. 7) Briefly, lyophilized BO formulation was reconstituted with pH 7.0 phosphate buffer to make a 3.2 mg/ml BO solution. The solution was added to a preincubated (37°C) buffer containing BSA, bilirubin and sodium cholate, and the decrease in absorbance at 460 nm was monitored. BO activity was determined within 30 min of reconstitution.
Enzyme activity of GA was measured as described previously. 10) Lyophilized GA formulations were dissolved in distilled water to make 1 mg/ml GA solution. The activity was determined using 2-nitrophenyl-b-Dgalactopyranoside as a substrate. Figure 1 shows the enzyme activity of BO and GA remaining after lyophilization with various polymer excipients. This value is expressed as a percentage of the enzyme activity of the solutions prior to lyophilization. When dextran was used as the excipient, marked inactivation during lyophilization was observed in both BO and GA formulations. When lyophilized with PVA, BO exhibited a marked decrease in activity, whereas GA showed no significant decrease. Lyophilization with PAA yielded BO and GA formulations with a relatively high remaining activity. BO and GA formulations with the highest remaining activity of more than 90% were obtained when PHEA was used as the excipient. Figure 2 shows the effect of solid-state rehydration and subsequent storage on the enzyme activity of lyophilized BO and GA formulations. The rear columns represent the enzyme activity remaining after solid-state rehydration under various humidity conditions. For the BO formulations (upper figures), the remaining activity decreased with increasing humidity for the formulations lyophilized with dextran, whereas an increase in remaining activity with increasing humidity was observed for the formulations lyophilized with PVA. The effect of humidity conditions on the remaining activity was not significant for the formulations lyophilized with PAA and PHEA. In contrast, the GA formulations (lower figures) exhibited an increase in remaining activity with increasing humidity for any formulations lyophilized with dextran, PAA or PHEA.
Results

Inactivation during Lyophilization
Inactivation during Storage The front columns in Fig.  2 represent the enzyme activity remaining after storage (at 70°C for 5 h) of the lyophilized BO and GA formulations with water absorbed at various humidities. The remaining activity of the lyophilized formulation without solid-state rehydration is also shown. This figure shows that the formulations containing dextran and PAA were relatively unstable. All the formulations studied exhibited lower storage stability without solid-state rehydration compared to the samples rehydrated at 23.4%RH. On the other hand, solid-state rehydration under higher humidity decreased the storage stability of formulations lyophilized with PVA, PAA and PHEA, except the GA formulation containing PHEA in which the stability was very high. Storage stability did not decrease remarkably with increasing humidity in the formulations lyophilized with dextran.
Discussion
Denaturation of BO and GA during lyophilization largely depended on the excipient used. Dextran appeared to induce severe damage in proteins, whereas PHEA protected proteins effectively from denaturation, as shown in Fig. 1 . The enzyme activity of the BO formulation lyophilized with PHEA, which was determined after rehydration in buffer, was more than 90% of the solutions prior to lyophilization. This is higher than the activity reported for BO formulations lyophilized with trehalose, 7) which is an effective stabilizer against protein denaturation during dehydration. It is well known that excipients with ability to hydrogen bond to the protein can inhibit protein denaturation during lyophilization.
1) The stabilizing effect of PHEA may be due to its flexible hydrophilic groups that can interact with protein. Dextran, which is considered to be too bulky to hydrogen bond to protein, 1) may cause substantial denaturation of BO and GA during lyophilization.
The effect of excipients on protein denaturation during lyophilization naturally varies with the properties of the proteins. PVA inhibited GA almost completely from denaturation during lyophilization, but its stabilizing effect was not as effective for BO, as shown in Fig. 1 . GA generally appears to be more stable than BO. When dextran was used as the excipient, marked inactivation during lyophilization was observed in both BO and GA formulations. Some of the activity loss in the GA formulations was recovered by solid-state rehydration, whereas solid-state rehydration caused further denaturation rather than activity recovery in the BO formulations, as shown in Fig. 2 . These findings suggest that GA undergoes partially reversible structural damage during lyophilization, indicating a lower degree of damage than that which occurs in BO formulations.
The storage stability of BO and GA formulations was improved by absorption of a small amount of water (Fig. 2) , suggesting that protein structure damage during lyophilization can be repaired to provide a more stable structure by appropriate solid-state rehydration. However, absorption of a larger amount of water decreased storage stability for most formulations. The decrease in storage stability with increasing absorption of water can be ascribed to an increase in molecular mobility with the absorption. This effect appeared 284 Vol. 48, No. 2
Fig. 1. Enzyme Activity of BO and GA Remaining after Lyophilization with Various Polymer Excipients
Expressed as a percentage of the enzyme activity of solutions prior to lyophilization (nϭ3, standard error: less than 4% for BO and less than 3% for GA). to vary according to the excipient used, such that formulations containing dextran did not exhibit as clear a decrease as formulations containing PVA, PAA or PHEA. This may be because formulations containing dextran have a higher glass transition temperature than formulations containing PVA, PAA or PHEA when a large amount of water absorption occurs. Although a decrease in storage stability with increasing water was also not observed in GA formulations containing PHEA, this may be due to the stabilizing effect of PHEA which inhibits protein unfolding/denaturation during lyophilization due to protein-excipient interaction.
Fig. 2. Enzyme Activity of Lyophilized BO and GA Formulations Containing Various Polymer Excipients
Remaining after solid-state rehydration under various humidity conditions (rear column) and after subsequent storage at 70°C for 5 h (front column), expressed as a percentage of the enzyme activity of solutions prior to lyophilization (nϭ3, standard error: less than 4% for BO and less than 3% for GA).
